DORB - Thanks drbio, I wasn't aware of the Osiris competition. Although the prior DORB trials were messy, the data suggested that a well-designed trial would be successful. And as you imply, now that they have the cash and the agreement with FDA on endpoint, it's mostly a matter of time. I've bought a small position, though it will probably be dead money for a year or two.
Market Data 
Markets 
AI
